Moreover, IFN-α2 expression was reduced but the miR-216a-3p expression was unchanged in the T2DM miR-216a-3p inhibitor + si-IFN-?2 group compared to the T2DM miR-216a-3p inhibitor group. This evidence concerns the gene IFNA1 and type 2 diabetes mellitus.